Benserazide, a dopadecarboxylase inhibitor, suppresses tumor growth by targeting hexokinase 2

Hexokinase (HK) is the rate-limiting enzyme in the first reaction of glycolysis. And Hexokinase 2 (HK2) is most closely related to malignant tumor which expresses at higher level compared with normal cells. HK...

from Cancer via ola Kala on Inoreader http://ift.tt/2pJ8NZa
via IFTTT